1,747 results on '"Creighton, Chad J"'
Search Results
152. Supplementary Figures 1 - 3 from Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma
153. Supplementary Figures 1-12 from Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases
154. Figure S8 from Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes
155. Supplementary Figure 1 from A Small-Molecule Inhibitor Targeting the Mitotic Spindle Checkpoint Impairs the Growth of Uterine Leiomyosarcoma
156. Supplementary Data 2 from Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases
157. Supplementary Figure Legend from T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo
158. Supplementary Data 1 from Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases
159. Supplementary 5 from Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases
160. Supplementary Information from Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression
161. Supplementary Table 3-8 from DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas
162. Supplementary Tables 1-4 from RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression
163. Tables S1-S6 from Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer
164. Data from Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer
165. Supplementary Figures S1-S4 from High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti–IGF-IR Therapy
166. Figures S1-S4 from Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer
167. Data from A Wnt-Independent LGR4–EGFR Signaling Axis in Cancer Metastasis
168. Data from High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti–IGF-IR Therapy
169. Data from Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII–p38MAPK–pS249/T252RB Pathway
170. Supplementary Data from A Wnt-Independent LGR4–EGFR Signaling Axis in Cancer Metastasis
171. Supplementary Figure legends from MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer
172. Data from MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer
173. Supplementary Figures 1-2 from Survivin Is a Viable Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors
174. Supplementary Tables 1 - 4 from Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma
175. Supplementary Table 10-12 from DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas
176. Supplementary Methods from Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma
177. Supplementary Figure 2 from A Small-Molecule Inhibitor Targeting the Mitotic Spindle Checkpoint Impairs the Growth of Uterine Leiomyosarcoma
178. Supplementary Figure 5 from T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo
179. Supplementary Figure 1 from MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer
180. Supplementary Figure from Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression
181. Supplementary Figures 1-6 from RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression
182. Supplementary Data 3 from Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases
183. Supplementary Data from Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer
184. Supplementary Figure 2 from MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer
185. Supplementary Methods from Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases
186. Supplementary Table 9 from DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas
187. Supplementary Table 2 from DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas
188. Supplementary Table from Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression
189. Supplementary Figures 1-4 from Pten Inactivation Accelerates Oncogenic K-ras–Initiated Tumorigenesis in a Mouse Model of Lung Cancer
190. Data from FGFR1–WNT–TGF-β Signaling in Prostate Cancer Mouse Models Recapitulates Human Reactive Stroma
191. Data from Bone Marrow Stroma–Secreted Cytokines Protect JAK2V617F-Mutated Cells from the Effects of a JAK2 Inhibitor
192. Supplementary Figure Legends from Endocrine Fibroblast Growth Factor FGF19 Promotes Prostate Cancer Progression
193. Data from Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers
194. Supplementary Tables from Integrative Radiogenomic Profiling of Squamous Cell Lung Cancer
195. Data from Development of Resistance to Targeted Therapies Transforms the Clinically Associated Molecular Profile Subtype of Breast Tumor Xenografts
196. Data from MiR-155 Is a Liposarcoma Oncogene That Targets Casein Kinase-1α and Enhances β-Catenin Signaling
197. Supplementary Figure 2 from Integrative Radiogenomic Profiling of Squamous Cell Lung Cancer
198. Supplemental Table 1 from Fibroblast Growth Factor Receptor Signaling Dramatically Accelerates Tumorigenesis and Enhances Oncoprotein Translation in the Mouse Mammary Tumor Virus–Wnt-1 Mouse Model of Breast Cancer
199. Supplementary Table 7 from Targets of the Tumor Suppressor miR-200 in Regulation of the Epithelial–Mesenchymal Transition in Cancer
200. Supplemental Table 3 from Fibroblast Growth Factor Receptor Signaling Dramatically Accelerates Tumorigenesis and Enhances Oncoprotein Translation in the Mouse Mammary Tumor Virus–Wnt-1 Mouse Model of Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.